van Schaik B A, van Nistelrooy A E, Geyskes G G
Br J Clin Pharmacol. 1984 Jul;18(1):57-63. doi: 10.1111/j.1365-2125.1984.tb05022.x.
Both the acute blood pressure lowering and renal effects of the calcium antagonist nicardipine and those after 1 week's treatment were investigated in 10 normotensive volunteers and in 10 patients with mild to moderate essential hypertension. After 1 week of placebo, nicardipine was administered orally for 1 week (20 mg three times daily), Investigations, done on the first and last day of nicardipine treatment were compared with those on the last day of placebo. During water loading, nicardipine increased urinary volume and urinary excretion of sodium significantly after 1 week nicardipine treatment. In the normotensive group the natriuretic effect was caused by a decrease of fractional proximal and distal reabsorption of sodium. In the hypertensive group the natriuresis was achieved mainly by an increase of the rate of glomerular filtration (GFR) and also by a slight distal effect. Our results show that nicardipine had natriuretic effects. There were trends suggesting that the renal effects may differ between patients with essential hypertension and normotensive volunteers, but the findings might also be related to differences in age between the groups.
在10名血压正常的志愿者和10名轻度至中度原发性高血压患者中,研究了钙拮抗剂尼卡地平的急性降压作用和肾脏效应以及治疗1周后的情况。在服用1周安慰剂后,口服尼卡地平1周(每日3次,每次20毫克),将尼卡地平治疗第1天和最后1天的检查结果与安慰剂最后1天的结果进行比较。在水负荷试验中,尼卡地平治疗1周后显著增加尿量和尿钠排泄。在血压正常组中,利钠作用是由近端和远端钠重吸收率降低引起的。在高血压组中,利钠作用主要通过肾小球滤过率(GFR)增加以及轻微的远端效应实现。我们的结果表明,尼卡地平有利钠作用。有趋势表明,原发性高血压患者和血压正常志愿者的肾脏效应可能不同,但这些发现也可能与两组年龄差异有关。